`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
` ____________
`
`UNIFIED PATENTS, LLC
`Petitioner
`
`v.
`
`MEMORYWEB, LLC
`Patent Owner
`____________
`
`Case No. IPR2021-01413
`Patent 10,621,228
` ____________
`
`
`PETITIONER’S MOTION TO EXCLUDE
`
`
`
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`In accordance with 37 C.F.R. § 42.64(c), Petitioner Unified Patents, LLC
`
`(“Petitioner”) respectfully moves to exclude Exhibits 2041, 2042, and 2045.
`
`Petitioner timely objected to these exhibits in its objections to evidence filed October
`
`18, 2022,1 within five business days of service of the evidence. Paper 38.
`
`I. EXHIBITS 2041, 2042, AND 2045 WERE FILED IN VIOLATION OF
`37 C.F.R. § 42.23(b) AND SHOULD BE EXCLUDED
`
`37 C.F.R. § 42.23(b) is clear: “[a] sur-reply may only respond to arguments
`
`raised in the corresponding reply and may not be accompanied by new evidence
`
`other than deposition transcripts of the cross-examination of any reply
`
`witness.”2 37 C.F.R. § 42.23(b); see also Consolidated Trial Practice Guide, 73
`
`(“[t]he sur-reply may not be accompanied by new evidence other than deposition
`
`transcripts of the cross-examination of any reply witness”). The Board has
`
`
`
` Petitioner objected to Exhibits 2041, 2042, and 2045 under 37 C.F.R. § 42.23(b) in its
`
` 1
`
`filed objections to evidence, as well as during Dr. Bederson’s reply deposition when they
`
`were introduced by Patent Owner. See Paper 38, 1; see, e.g., EX2046, 52:7-25, 59:7-20,
`
`79:18-80:2.
`
`2 Bolding indicates emphasis added unless otherwise noted.
`
`
`
`1
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`explained that “Rule 42.23(b) provides a blanket prohibition on the patentee filing
`
`new exhibits (other than deposition transcripts of the cross-examination of any reply
`
`witness) with a sur-reply.” See, e.g., Netflix v. Divx, IPR2020-00511, Paper 46, 54
`
`(PTAB Aug. 13, 2021); Intel Corp. v. Parkervision, Inc., IPR2020- 01265, Paper 44,
`
`74 (PTAB Jan. 21, 2022); Hamilton Techs. LLC v. Fleur Tehrani, IPR2020-01199,
`
`Paper 57, 51-54 (PTAB Dec. 28, 2021).
`
`Patent Owner filed Exhibits 2041, 2042, and 20453 with its Sur-Reply (Paper
`
`35) on October 11, 2022.4 These exhibits are not deposition transcripts. Therefore,
`
`Exhibits 2041, 2042, and 2045 must be excluded under 37 C.F.R. § 42.23(b).
`
`
`
` Patent Owner introduced Exhibits 2041, 2042, and 2045 for the first time during the reply
`
` 3
`
`deposition of Dr. Bederson. EX2046, 52:7-25, 59:7-20, 79:18-80:2. Patent Owner’s use of
`
`these exhibits during this deposition was improper under 37 C.F.R. § 42.53 (d)(5)(ii) as it
`
`exceeded the scope of the direct testimony in Dr. Bederson’s reply declaration (EX1038).
`
`4 Patent Owner also filed Exhibits 2043 and 2044 with its Sur-Reply, which Petitioner
`
`Objected to. Paper 38. Per the Board’s authorization, Petitioner filed a Sur-Sur Reply
`
`
`
`
`
`
`2
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`To the extent Patent Owner argues Exhibits 2041, 2042, and 2045 are
`
`admissible in the interests of justice because they constitute deposition evidence that
`
`provide context for Dr. Bederson’s testimony, this argument fails. Patent Owner
`
`does not rely on Exhibits 2041, 2042, or 2045, or Dr. Bederson’s testimony
`
`regarding these exhibits, in its Sur-Reply (or any of its other papers). Moreover,
`
`Patent Owner introduced Exhibits 2041, 2042, and 2045 for the first-time during Dr.
`
`Bederson’s reply deposition and did not serve them to Petitioner in advance of the
`
`deposition. EX2046, 52:7-25, 59:7-20, 79:18-80:2.5 Dr. Bederson testified during
`
`that deposition that he had not seen these exhibits before in this proceeding and was
`
`not familiar with them. Id., 190:3-12. Exhibits 2041, 2042, and 2045 therefore do
`
`not provide context for Dr. Bederson’s testimony and are not reliable to test his
`
`
`addressing the portions of Patent Owner’s Sur-Reply that relied on these exhibits. Paper
`
`
`
`42. Therefore, these exhibits are not subject to this Motion.
`
`5 Patent Owner introduced these exhibits at such a late stage of the proceeding even
`
`though it could have introduced them earlier, such as with its Patent Owner Response
`
`or during Dr. Bederson’s first deposition, but chose not to.
`
`
`
`
`
`3
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`opinions, and should be excluded; the interests of justice do not necessitate
`
`otherwise. See Netflix, IPR2020-00511, Paper 46, 52–55 (Board granting motion to
`
`exclude exhibits introduced during reply deposition and filed by patent owner with
`
`its Sur-Reply, finding that since the exhibits did not provide context for deposition
`
`testimony as the declarant testified he had not seen the exhibits before, the interests
`
`of justice did not weigh in favor of maintaining the exhibits); see also Netflix, Inc.
`
`v. DivX, LLC, IPR2020-00558, Paper 50, 32-36 (PTAB Aug. 23, 2021) (Board
`
`granting motion to exclude exhibit introduced during reply deposition and filed by
`
`patent owner with its Sur-Reply, finding that since the exhibit did not provide
`
`context for deposition testimony as the declarant testified he had not prepared for
`
`the deposition using the newly introduced exhibit, the interests of justice did not
`
`weigh in favor of maintaining the exhibit).
`
`II. EXHIBITS 2041, 2042, AND 2045 SHOULD BE EXCLUDED UNDER
`THE FEDERAL RULES OF EVIDENCE (“FRE”) 401-403
`
`The FRE apply to this proceeding. See 37 C.F.R. § 42.62. The Board may
`
`
`
`exercise its discretion to exclude evidence entirely, or alternatively, may decline to
`
`consider evidence. CBS Interactive Inc. v. Helferich Patent Licensing, LLC,
`
`IPR2013-00033, Paper 79, 3 (PTAB Aug. 9, 2013). According to FRE 401
`
`
`
`4
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`“Evidence is relevant if: (a) it has any tendency to make a fact more or less probable
`
`than it would be without the evidence; and (b) the fact is of consequence in
`
`determining the action.” FRE 401. “Relevancy is not an inherent characteristic
`
`of any item of evidence.” FRE 401 Notes of Advisory Committee. “The standard
`
`of probability under the rule is ‘more probable than it would be without the
`
`evidence.’” Id. According to FRE 402, “[i]rrelevant evidence is not admissible.”
`
`FRE 402. FRE 403 adds that relevant evidence may be excluded “if its probative
`
`value is substantially outweighed by a danger of one or more of the following: unfair
`
`prejudice, confusing the issues, misleading the jury, undue delay, wasting time, or
`
`needlessly presenting cumulative evidence.” FRE 403.
`
`As discussed above, Patent Owner introduced Exhibits 2041, 2042, and 2045
`
`for the first-time during Dr. Bederson’s reply deposition and filed them with its Sur-
`
`Reply. Supra, 2-3. But Patent Owner does not rely on Exhibits 2041, 2042, or 2045
`
`in its Sur-Reply (or in any of its other papers), and likewise does not rely on any
`
`deposition testimony of Dr. Bederson regarding these exhibits. Thus, these exhibits
`
`have no bearing on any facts in the case, much less have “any tendency to make a
`
`fact more or less probable than it would be without” the exhibits. FRE 401. The
`
`exhibits are not “relevant” within the meaning of the Federal Rules of Evidence.
`5
`
`
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`Id. Thus, the irrelevant exhibits are not admissible. FRE 402; see also, e.g., SK
`
`Innovation Co., Ltd. v. Celgard, LLC, IPR2014-00679, Paper 58, 49 (PTAB Sept. 25,
`
`2015), Shimano Inc., v. Globeride, Inc., IPR2015-00273, Paper 40, 27-28 (PTAB
`
`June 16, 2016) (each granting motion to exclude uncited exhibits).
`
`Even if Exhibits 2041, 2042, and 2045 were relevant (which they are not),
`
`they have minimal probative value that is substantially outweighed by dangers of
`
`unfair prejudice, confusing the issues, undue delay, and wasting time. FRE 403. As
`
`discussed, Patent Owner does not cite to any to any of the exhibits or testimony
`
`addressing the exhibits. Thus, the exhibits have little to no probative value. And
`
`Exhibits 2041, 2042, and 2045 create a myriad of dangers contemplated by the FRE.
`
`They serve only as noise to distract from the proceeding and unduly waste both the
`
`Board’s and Petitioner’s time as being evidence that is not used. They also confuse
`
`the issues by adding to the record evidence that, due to their none-use by Patent
`
`Owner, has no bearing on the issues. For the same reasons, Exhibits 2041, 2042, and
`
`2045 create a risk of side issues in this proceeding and any appeal therefrom.
`
`Accordingly, Exhibits 2041, 2042, and 2045 should be excluded. FRE 403.
`
`
`
`
`
`
`
`6
`
`
`
`
`
`
`
`
`
`Date: November 22, 2022
`
`
`
`
`
`
`
`
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`Respectfully submitted,
`
`/Ellyar Y. Barazesh/
`Ellyar Y. Barazesh
`Reg. No. 74,096
`Counsel for Petitioner
`
`
`
`7
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`
`The undersigned hereby certifies
`
`that a copy of
`
`the
`
`foregoing
`
`
`
`
`PETITIONER’S MOTION TO EXCLUDE was served on November 22, 2022, via
`
`electronic mail, as agreed to by counsel, upon the following counsel for Patent
`
`Owner:
`
`
`
`Jennifer Hayes
`Nixon Peabody LLP
`300 South Grand Avenue, Suite 4100
`Los Angeles, CA 90071-3151
`jenhayes@nixonpeabody.com
`
`George Dandalides
`Nixon Peabody LLP
`70 West Madison, Suite 5200
`Chicago, IL 60602-4224
`gdandalides@nixonpeabody.com
`
`Matthew A. Werber
`Nixon Peabody LLP
`70 West Madison, Suite 5200
`Chicago, IL 60602-4224
`mwerber@nixonpeabody.com
`
`
`
`Date: November 22, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Ashley F. Cheung/
`Ashley F. Cheung
`Paralegal
`Unified Patents, LLC
`
`
`
`
`
`